Pfizer Pharma
- All
- News
- Videos
-
The Era Of Anti-Covid Pills: What You Need To Know
US pharma giants Merck and Pfizer have announced encouraging results for oral aniviral pills, in what could open up a new chapter in the fight against the COVID-19 pandemic.
-
Expert Group In Talks With Pfizer For Vaccine Supply: Health Minister
An expert group of the Indian government is in talks with global pharma major Pfizer over COVID vaccine supply, said Union Health Minister Mansukh Mandaviya on Friday.
-
"Will Only Work With Centre," Says Pfizer As States' Vaccine Bids Falter
States scrambling to buy Covid vaccines directly from foreign manufacturers, to boost what they say is insufficient supply from the centre, seem to be running into a roadblock in some cases, with at least two pharma giants refusing to sell to them.
-
"Largest Humanitarian Relief Effort In Our History": Pfizer On India Aid
Global pharma major Pfizer is sending its medicines worth USD 70 million (over Rs 510 crore), from its distribution centres in the US, Europe and Asia, that have been identified as part of India's COVID-19 treatment protocol.
-
Pfizer Covid Vaccine Not Recommended For Emergency Use 'At This Stage': Expert Panel
Just two days before pharma major Pfizer announced withdrawal of its application for emergency use authorisation of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage, officials told news agency Press Trust of India on Friday.
-
Pfizer Withdraws Emergency Use Request For Its Covid Vaccine In India
Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine in India.
-
Factory Renovation Delays European Union's Pfizer Vaccine Deliveries By 3-4 Weeks
Deliveries of the coronavirus vaccine developed by BioNTech and Pfizer to EU nations will be delayed in the coming weeks because of works at the US pharma firm's plant in Belgium, Germany's health ministry said Friday.
-
"Short Notice, Different Time Zone": Pfizer On Delay In Vaccine Approval
US pharma giant Pfizer, whose Covid vaccine has yet be approved, told NDTV on Monday that it had been "unable to participate in previous meetings (to present safety and efficacy data) due to extremely short notice" and time zone differences
-
After Pfizer, Serum Institute Of India Seeks Approval For Covid Vaccine
Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca, sources have said.
-
Pfizer Seeks India Approval For Covid Vaccine, First To Do So: Sources
American pharma giant Pfizer has sought approval from the country's drug regulator - the DCGI (Drugs Controller General of India) - for emergency use authorisation of its coronavirus vaccine, say sources. The vaccine is ready to be rolled out in the United Kingdom and Bahrain.
-
The Era Of Anti-Covid Pills: What You Need To Know
US pharma giants Merck and Pfizer have announced encouraging results for oral aniviral pills, in what could open up a new chapter in the fight against the COVID-19 pandemic.
-
Expert Group In Talks With Pfizer For Vaccine Supply: Health Minister
An expert group of the Indian government is in talks with global pharma major Pfizer over COVID vaccine supply, said Union Health Minister Mansukh Mandaviya on Friday.
-
"Will Only Work With Centre," Says Pfizer As States' Vaccine Bids Falter
States scrambling to buy Covid vaccines directly from foreign manufacturers, to boost what they say is insufficient supply from the centre, seem to be running into a roadblock in some cases, with at least two pharma giants refusing to sell to them.
-
"Largest Humanitarian Relief Effort In Our History": Pfizer On India Aid
Global pharma major Pfizer is sending its medicines worth USD 70 million (over Rs 510 crore), from its distribution centres in the US, Europe and Asia, that have been identified as part of India's COVID-19 treatment protocol.
-
Pfizer Covid Vaccine Not Recommended For Emergency Use 'At This Stage': Expert Panel
Just two days before pharma major Pfizer announced withdrawal of its application for emergency use authorisation of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage, officials told news agency Press Trust of India on Friday.
-
Pfizer Withdraws Emergency Use Request For Its Covid Vaccine In India
Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine in India.
-
Factory Renovation Delays European Union's Pfizer Vaccine Deliveries By 3-4 Weeks
Deliveries of the coronavirus vaccine developed by BioNTech and Pfizer to EU nations will be delayed in the coming weeks because of works at the US pharma firm's plant in Belgium, Germany's health ministry said Friday.
-
"Short Notice, Different Time Zone": Pfizer On Delay In Vaccine Approval
US pharma giant Pfizer, whose Covid vaccine has yet be approved, told NDTV on Monday that it had been "unable to participate in previous meetings (to present safety and efficacy data) due to extremely short notice" and time zone differences
-
After Pfizer, Serum Institute Of India Seeks Approval For Covid Vaccine
Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca, sources have said.
-
Pfizer Seeks India Approval For Covid Vaccine, First To Do So: Sources
American pharma giant Pfizer has sought approval from the country's drug regulator - the DCGI (Drugs Controller General of India) - for emergency use authorisation of its coronavirus vaccine, say sources. The vaccine is ready to be rolled out in the United Kingdom and Bahrain.
